Christopher E. Loh

Partner
Loh Christopher

Chris Loh practices complex patent litigation in the areas of pharmaceuticals, biotechnology, and chemistry. As lead or co-counsel, Chris has litigated patent cases involving oncology therapies, anti-HIV therapies, anti-hepatitis drugs, antidepressants, and statins. He has argued before numerous federal district courts and the United States Court of Appeals for the Federal Circuit, and has won in inter partes review (IPR) proceedings before the Patent Trial and Appeal Board (PTAB), on behalf of patent owners.

In addition to his litigation work, Chris counsels clients on transactional and patent prosecution issues concerning both small-molecule drugs and biological products, such as recombinant antibodies. He also provides advice on a range of intellectual property matters, including inventorship, trade secrets, and licensing.

Experience

Representative Matters

  • Represented Novartis Pharmaceuticals Corp. against multiple defendants in cases concerning patents for Novartis’s Alzheimer’s disease treatment, Exelon® Patch (rivastigmine)
  • Represented Novartis AG against Teva Pharmaceuticals USA, Inc. in a case concerning patents for Novartis’s organ transplant rejection therapy, Myfortic® (mycophenolic acid)
  • Represented Genzyme Corporation against multiple defendants in cases concerning patents for Genzyme’s renal disease treatment, Hectorol® (doxercalciferol)
  • Represented Novartis Pharmaceuticals Corp. against Mylan Pharmaceuticals, Inc. in a case concerning patents for Novartis’s statin drug, Lescol® (fluvastatin)
  • Represented Adams Respiratory Therapeutics, Inc. against Mutual Pharmaceutical Co., Inc. in a case concerning patents for Adams’ antitussive drug, Mucinex® (guaifenisen)
  • Represented AstraZeneca Pharmaceuticals LP against multiple defendants in cases concerning patents for AstraZeneca’s anticonvulsive and antidepressant medication, Seroquel® (quetiapine)
  • Represented IBM Corp. against Sky Technologies Inc. in a case concerning patents for Sky’s automated negotiation software
  • Represented Novartis Pharmaceuticals Corp. against Dr. Reddy’s Laboratories, Ltd. in a case concerning patents for Novartis’s antifungal treatment, Lamisil® (terbinafine)
  • Represented Bausch & Lomb Inc. against Allergan Inc. in a case concerning patents for Allergan’s glaucoma drug, Alphagan® (brimonidine)
  • Represented AstraZeneca AB against Mutual Pharmaceutical Co., Inc. in a case concerning patents for AstraZeneca’s antihypertensive medication, Plendil® (felodipine)

Representative Clients

  • Adams Respiratory Therapeutics
  • Akros Pharma
  • AstraZeneca
  • Bausch & Lomb Inc.
  • Genzyme
  • Gilead
  • LEO Pharma
  • Novartis
  • Sanofi

Insights

Credentials
+

Education

  • J.D. Columbia Law School 1998
  • Harlan Fiske Stone Scholar

    Notes editor, Columbia Business Law Review

    Intern, New York Volunteer Lawyers for the Arts

  • B.S. Yale University 1995

Bar Admissions

  • New York

Court Admissions

  • U.S. Patent and Trademark Office
  • U.S. District Court for the Eastern District of Michigan
  • U.S. District Court for the Southern District of New York
  • U.S. District Court for the Eastern District of New York
  • Court of Appeals for the Federal Circuit

Professional Memberships and Activities

  • Frequent author on intellectual property issues; articles have appeared in Lexology, the National Law Journal, the New York Law Journal, Bloomberg IP, and Managing Intellectual Property
  • Presented at the BIO IPCC Counsels conference and the New Jersey Intellectual Property Law Association Pharmaceutical/Chemical Patent Practice Update
  • Taught for Lawline

Recognition
+

  • Two-time recipient, Burton Award for Legal Achievement, in recognition of exceptional writing, 2006, 2008